Lipoprotein(a): Cellular effects and molecular mechanisms

Cholesterol

Volumn 2012, Issue , 2012, Pages

  Riches, Kirsten ^a   Porter, Karen E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; ALPHA2BETA3 INTEGRIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHEMOATTRACTANT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPID; PLASMIN; PLASMINOGEN; THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; BLOOD CLOTTING; CARDIOVASCULAR SYSTEM; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CHEMOTAXIS; CROHN DISEASE; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; INFLAMMATORY CELL; LIPID TRANSPORT; MACROPHAGE; MOLECULAR BIOLOGY; MONOCYTE; PATHOGENESIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 84867006596     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2012/923289     Document Type: Review

References (74)

1. Marcovina S. M., Koschinsky M. L., Albers J. J., Skarlatos S., Report of the national heart, lung, and blood institute workshop on Lipoprotein(a) and cardiovascular disease: recent advances and future directions. Clinical Chemistry 2003 49 11 1785 1796 2-s2.0-0242331117 10.1373/clinchem.2003.023689 (Pubitemid 37340313)
2. Frank S., Durovic S., Kostner G. M., The assembly of lipoprotein Lp(a). European Journal of Clinical Investigation 1996 26 2 109 114 2-s2.0-0030065762 (Pubitemid 26063434)
3. McCormick S. P., Lipoprotein(a): biology and clinical importance. The Clinical Biochemist Reviews 2004 25 1 69 80
4. Berg K., A new serum type system in manthe Lp system. Acta Pathologica et Microbiologica Scandinavica 1963 59 369 382 2-s2.0-47649091099
5. Kostner G. M., Avogaro P., Cazzolato G., Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981 38 1-2 51 61 2-s2.0-0019454874 (Pubitemid 11138606)
6. Dahlen G. H., Guyton J. R., Attar M., Farmer J. A., Kautz J. A., Gotto A. M. Jr, Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986 74 4 758 765 2-s2.0-0022515518 (Pubitemid 16007192)
7. Yano Y., Shimokawa K., Okada Y., Noma A., Immunolocalization of lipoprotein(a) in wounded tissues. Journal of Histochemistry and Cytochemistry 1997 45 4 559 568 2-s2.0-0030909813 (Pubitemid 27175800)
8. von Zychlinski A., Kleffmann T., Williams M. J. A., McCormick S. P., Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding. Journal of Proteomics 2011 74 12 2881 2891 10.1016/j.jprot.2011.07.008
9. Lippi G., Targher G., Optimal therapy for reduction of lipoprotein(a). Journal of Clinical Pharmacy and Therapeutics 2012 37 1 1 3 10.1111/j.1365-2710. 2011.01244.x
10. Davì G., Patrono C., Mechanisms of disease: platelet activation and atherothrombosis. New England Journal of Medicine 2007 357 24 2482 2494 2-s2.0-37249068049 10.1056/NEJMra071014 (Pubitemid 350272787)
11. Rand M. L., Sangrar W., Hancock M. A., Taylor D. M., Marcovina S. M., Packham M. A., Koschinsky M. L., Apolipoprotein(a) enhances platelet responses to the thrombin receptor- activating peptide SFLLRN. Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 9 1393 1399 2-s2.0-0031713182 (Pubitemid 28421876)
12. Martínez C., Rivera J., Loyau S., Corral J., González- Conejero R., Lozano M. L., Vicente V., Anglés-Cano E., Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation. Thrombosis and Haemostasis 2001 85 4 686 693 2-s2.0-0035070810 (Pubitemid 32293706)
13. Gries A., Gries M., Wurm H., Kenner T., Ijsseldijk M., Sixma J. J., Kostner G. M., Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes. Arteriosclerosis, Thrombosis, and Vascular Biology 1996 16 5 648 655 2-s2.0-0029897984 (Pubitemid 26153109)
14. Tsironis L. D., Mitsios J. V., Milionis H. J., Elisaf M., Tselepis A. D., Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase. Cardiovascular Research 2004 63 1 130 138 2-s2.0-2942516211 10.1016/j.cardiores. 2004.03.005 (Pubitemid 38759817)
15. Karabina S. A. P., Elisaf M. C., Goudevenos J., Siamopoulos K. C., Sideris D., Tselepis A. D., PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro. Atherosclerosis 1996 125 1 121 134 2-s2.0-0030599042 10.1016/0021-9150(96)05872-8 (Pubitemid 26267129)
16. Barre D. E., Apoprotein (a) antagonises the GPIIb/IIIa receptor on collagen and ADP-stimulated human platelets. Frontiers in Bioscience 2004 9 404 410 2-s2.0-1642334187 (Pubitemid 38925469)
17. Malle E., Ibovnik A., Steinmetz A., Kostner G. M., Sattler W., Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets: Lipoprotein(a) binding is independent of an arginyl-glycyl- aspartate tripeptide located in apolipoprotein(a). Arteriosclerosis and Thrombosis 1994 14 3 345 352 2-s2.0-0028326663
18. Mackman N., Role of tissue factor in hemostasis, thrombosis, and vascular development. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 6 1015 1022 2-s2.0-2942517677 10.1161/01.ATV.0000130465.23430.74 (Pubitemid 38737825)
19. Sotiriou S. N., Orlova V. V., Al-Fakhri N., Ihanus E., Economopoulou M., Isermann B., Bdeir K., Nawroth P. P., Preissner K. T., Gahmberg C. G., Koschinsky M. L., Chavakis T., Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB Journal 2006 20 3 559 561 2-s2.0-33645838815 10.1096/fj.05-4857fje (Pubitemid 46671249)
20. Etingin O. R., Hajjar D. P., Hajjar K. A., Harpel P. C., Nachman R. L., Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: a potential mechanism in thrombogenesis. Journal of Biological Chemistry 1991 266 4 2459 2465 2-s2.0-0025766634 (Pubitemid 21909085)
21. Caplice N. M., Panetta C., Peterson T. E., Kleppe L. S., Mueske C. S., Kostner G. M., Broze G. J. Jr, Simari R. D., Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 2001 98 10 2980 2987 2-s2.0-0035892139 10.1182/blood.V98.10.2980
22. Hancock M. A., Boffa M. B., Marcovina S. M., Nesheim M. E., Koschinsky M. L., Inhibition of plasminogen activation by lipoprotein(a). Critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces. Journal of Biological Chemistry 2003 278 26 23260 23269 2-s2.0-0038268795 10.1074/jbc.M302780200 (Pubitemid 36830139)
23. Loscalzo J., Weinfeld M., Fless G. M., Scanu A. M., Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990 10 2 240 245 2-s2.0-0025323352 (Pubitemid 20103586)
24. Rouy D., Grailhe P., Nigon F., Chapman J., Angles-Cano E., Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator: in vitro studies in a plasma milieu. Arteriosclerosis and Thrombosis 1991 11 3 629 638 2-s2.0-0025764362
25. Levin E. G., Miles L. A., Fless G. M., Scanu A. M., Baynham P., Curtiss L. K., Plow E. F., Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells. Arteriosclerosis and Thrombosis 1994 14 3 438 442 2-s2.0-0028215089
26. Zhang J., Ren S., Shen G. X., Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells. Atherosclerosis 2000 150 2 299 308 2-s2.0-0034081217 10.1016/S0021-9150(99)00381-0 (Pubitemid 30336542)
27. Ren S., Shatadal S., Shen G. X., Protein kinase C- β mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells. American Journal of Physiology-Endocrinology and Metabolism 2000 278 4 E656 E662 2-s2.0-0034004141 (Pubitemid 30215176)
28. Ren S., Man R. Y. K., Angel A., Shen G. X., Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells. Atherosclerosis 1997 128 1 1 10 2-s2.0-0031043615 10.1016/S0021-9150(96)05971-0 (Pubitemid 27065255)
29. Lyons R. M., Gentry L. E., Purchio A. F., Moses H. L., Mechanism of activation of latent recombinant transforming growth factor β 1 by plasmin. Journal of Cell Biology 1990 110 4 1361 1367 2-s2.0-0025215307
30. Owens G. K., Geisterfer A. A. T., Wei-Hwa Yang Y., Komoriya A., Transforming growth factor- β -induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. Journal of Cell Biology 1988 107 2 771 780 2-s2.0-0023747397
31. Heimark R. L., Twardzik D. R., Schwartz S. M., Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 1986 233 4768 1078 1080 2-s2.0-0022492518 (Pubitemid 16032237)
32. Suzuki Y., Tanigaki T., Heimer D., Wang W., Ross W. G., Murphy G. A., Sakai A., Sussman H. H., Vu T. H., Raffin T. A., TGF- β 1 causes increased endothelial ICAM-1 expression and lung injury. Journal of Applied Physiology 1994 77 3 1281 1287 2-s2.0-0027958948 (Pubitemid 24299381)
33. Ramharack R., Barkalow D., Spahr M. A., Dominant negative effect of TGF- β 1 and TNF- α on basal and IL-6- induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 6 984 990 2-s2.0-0031745253 (Pubitemid 28272595)
34. Kojima S., Harpel P. C., Rifkin D. B., Lipoprotein (a) inhibits the generation of transforming growth factor β: an endogenous inhibitor of smooth muscle cell migration. Journal of Cell Biology 1991 113 6 1439 1445 2-s2.0-0025896187 (Pubitemid 21909770)
35. Miyata M., Biro S., Kaieda H., Tanaka H., Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways. FEBS Letters 1995 377 3 493 496 2-s2.0-0029593445 10.1016/0014- 5793(95)01404-7 (Pubitemid 26025741)
36. O'Neil C. H., Boffa M. B., Hancock M. A., Pickering J. G., Koschinsky M. L., Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor- β activation and on the presence of kringle IV type 9. Journal of Biological Chemistry 2004 279 53 55187 55195 2-s2.0-11244341059 10.1074/jbc.M409860200 (Pubitemid 40066513)
37. Liu L., Craig A. W., Meldrum H. D., Marcovina S. M., Elliott B. E., Koschinsky M. L., Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin α V β 3. Biochemical Journal 2009 418 2 325 336 2-s2.0-61449199538 10.1042/BJ20080744
38. Koutroubakis I. E., Malliaraki N., Vardas E., Ganotakis E., Margioris A. N., Manousos O. N., Kouroumalis E. A., Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis? European Journal of Gastroenterology and Hepatology 2001 13 12 1415 1419 2-s2.0-0035216261 10.1097/00042737- 200112000-00004 (Pubitemid 33151493)
39. Azuma H., Yamaguchi H., Mima N., Shirakawa M., Miyamoto K., Kanagawa Y., Watanabe A., Shigekiyo T., Saito S., An in vitro system for identifying agents capable of changing serum lipoprotein(a) concentration by regulating the transcriptional activity of the apolipoprotein(a) gene promoter. Biochemical and Biophysical Research Communications 1996 227 2 570 575 2-s2.0-0030583554 10.1006/bbrc.1996.1547 (Pubitemid 26362844)
40. MBewu A. D., Durrington P. N., Bulleid S., Mackness M. I., The immediate effect of streptokinase on serum lipoprotein(a) concentation and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein. Atherosclerosis 1993 103 1 65 71 2-s2.0-0027435729 10.1016/0021-9150(93)90040-2 (Pubitemid 23313140)
41. Tsimikas S., Bergmark C., Beyer R. W., Patel R., Pattison J., Miller E., Juliano J., Witztum J. L., Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. Journal of the American College of Cardiology 2003 41 3 360 370 2-s2.0-0037419857 10.1016/S0735-1097(02)02769-9 (Pubitemid 36164488)
42. Tsimikas S., Lau H. K., Han K. R., Shortal B., Miller E. R., Segev A., Curtiss L. K., Witztum J. L., Strauss B. H., Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 2004 109 25 3164 3170 2-s2.0-4544261604
43. Tsimikas S., Brilakis E. S., Miller E. R., McConnell J. P., Lennon R. J., Kornman K. S., Witztum J. L., Berger P. B., Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. New England Journal of Medicine 2005 353 1 46 57 2-s2.0-21444447949 10.1056/NEJMoa043175 (Pubitemid 41007806)
44. Edelstein C., Pfaffinger D., Hinman J., Miller E., Lipkind G., Tsimikas S., Bergmark C., Getz G. S., Witztum J. L., Scanu A. M., Lysine- phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). Journal of Biological Chemistry 2003 278 52 52841 52847 2-s2.0-9144233520 10.1074/jbc.M310425200 (Pubitemid 38035883)
45. Edelstein C., Philips B., Pfaffinger D., Scanu A. M., The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin. FASEB Journal 2009 23 3 950 956 2-s2.0-61449259919 10.1096/fj.08-122002
46. Bergmark C., Dewan A., Orsoni A., Merki E., Miller E. R., Shin M. J., Binder C. J., Hörkkö S., Krauss R. M., Chapman M. J., Witztum J. L., Tsimikas S., A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. Journal of Lipid Research 2008 49 10 2230 2239 2-s2.0-59049086968 10.1194/jlr.M800174-JLR200
47. Klezovitch O., Edelstein C., Scanu A. M., Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a): evidence for a critical involvement of elements in its C-terminal domain. Journal of Biological Chemistry 2001 276 50 46864 46869 2-s2.0-0035861663 10.1074/jbc.M107943200
48. Nakagami F., Nakagami H., Osako M. K., Iwabayashi M., Taniyama Y., Doi T., Shimizu H., Shimamura M., Rakugi H., Morishita R., Estrogen attenuates vascular remodeling in Lp(a) transgenic mice. Atherosclerosis 2010 211 1 41 47 2-s2.0-77954313453 10.1016/j.atherosclerosis.2010.01.016
49. Suk D. J., Rifai N., Buring J. E., Ridker P. M., Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. Journal of the American College of Cardiology 2008 52 2 124 131 2-s2.0-45849110333 10.1016/j.jacc.2008.04.009 (Pubitemid 351885446)
50. Boffelli D., Zajchowski D. A., Yang Z., Lawn R. M., Estrogen modulation of apolipoprotein(a) expression: identification of a regulatory element. Journal of Biological Chemistry 1999 274 22 15569 15574 2-s2.0-0032985561 10.1074/jbc.274.22.15569 (Pubitemid 29254927)
51. Haque N. S., Zhang X., French D. L., Li J., Poon M., Fallon J. T., Gabel B. R., Taubman M. B., Koschinsky M., Harpel P. C., CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 2000 102 7 786 792 2-s2.0-0033871183 (Pubitemid 30643286)
52. Kronenberg F., Kronenberg M. F., Kiechl S., Trenkwalder E., Santer P., Oberhollenzer F., Egger G., Utermann G., Willeit J., Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the bruneck study. Circulation 1999 100 11 1154 1160 2-s2.0-0033554451 (Pubitemid 29426589)
53. Syrovets T., Thillet J., Chapman M. J., Simmet T., Lipoprotein(a) is a potent chemoattractant for human peripheral monocytes. Blood 1997 90 5 2027 2036 2-s2.0-0030882882 (Pubitemid 27377316)
54. Kagawa A., Azuma H., Akaike M., Kanagawa Y., Matsumoto T., Aspirin reduces apolipoprotein(a) (Apo(a)) production in human hepatocytes by suppression of Apo(a) gene transcription. Journal of Biological Chemistry 1999 274 48 34111 34115 2-s2.0-0033607536 10.1074/jbc.274.48.34111 (Pubitemid 129511746)
55. Allen S., Khan S., Tam S. P., Koschinsky M., Taylor P., Yacoub M., Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity. FASEB Journal 1998 12 15 1765 1776 2-s2.0-0031729223 (Pubitemid 28553672)
56. Takami S., Yamashita S., Kihara S., Ishigami M., Takemura K., Kume N., Kita T., Matsuzawa Y., Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. Circulation 1998 97 8 721 728 2-s2.0-0032478089 (Pubitemid 28135333)
57. Ross R., Atherosclerosisan inflammatory disease. New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207 (Pubitemid 29054847)
58. Grainger D. J., Kirschenlohr H. L., Metcalfe J. C., Weissberg P. L., Wade D. P., Lawn R. M., Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993 260 5114 1655 1658 2-s2.0-0027220011 (Pubitemid 23247149)
59. Locher R., Brandes R. P., Vetter W., Barton M., Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases. Hypertension 2002 39 2 645 650 2-s2.0-0036181927 10.1161/hy0202.103473 (Pubitemid 34165199)
60. Makita T., Tanaka A., Numano F., Effect of glycated low density lipoprotein on smooth muscle cell proliferation. International Angiology 1999 18 4 331 334 2-s2.0-0033502311 (Pubitemid 30153811)
61. Mitra S., Goyal T., Mehta J. L., Oxidized LDL, LOX-1 and atherosclerosis. Cardiovascular Drugs and Therapy 2011 25 5 419 429 10.1007/s10557-011-6341-5
62. Komai N., Morishita R., Yamada S., Oishi M., Iguchi S., Aoki M., Sasaki M., Sakurabayashi I., Higaki J., Ogihara T., Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells. Hypertension 2002 40 3 310 314 2-s2.0-0036712069 10.1161/01.HYP.0000029974.50905.B4 (Pubitemid 35006716)
63. Zhao S. P., Xu D. Y., Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells. Clinica Chimica Acta 2000 296 1-2 121 133 2-s2.0-0034010660 10.1016/S0009- 8981(00)00214-X (Pubitemid 30243145)
64. Takahashi A., Taniguchi T., Fujioka Y., Ishikawa Y., Yokoyama M., Effects of lipoprotein(a) and low density lipoprotein on growth of mitogen-stimulated human umbilical vein endothelial cells. Atherosclerosis 1996 120 1-2 93 99 2-s2.0-0030048643 10.1016/0021-9150(95)05686-6 (Pubitemid 26053311)
65. Yano Y., Seishima M., Tokoro Y., Noma A., Stimulatory effects of lipoprotein(a) and low-density lipoprotein on human umbilical vein endothelial cell migration and proliferation are partially mediated by fibroblast growth factor-2. Biochimica et Biophysica Acta 1998 1393 1 26 34 2-s2.0-0032584505 10.1016/S0005-2760(98)00052-6 (Pubitemid 28495586)
66. Mondorf U. F., Piiper A., Herrero M., Olbrich H. G., Bender M., Gross W., Scheuermann E., Geiger H., Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins. Kidney International 1999 55 4 1359 1366 2-s2.0-0032920010 10.1046/j.1523-1755.1999.00367.x (Pubitemid 29157134)
67. Krämer-Guth A., Greiber S., Pavenstädt H., Quaschning T., Winkler K., Schollmeyer P., Wanner C., Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix. Kidney International 1996 49 5 1250 1261 2-s2.0-0029890079 (Pubitemid 26166401)
68. Galle J., Schneider R., Heinloth A., Wanner C., Galle P. R., Conzelmann E., Dimmeler S., Heermeier K., Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress. Kidney International 1999 55 4 1450 1461 2-s2.0-0032930114 10.1046/j.1523-1755.1999. 00351.x (Pubitemid 29157144)
69. Seimon T. A., Nadolski M. J., Liao X., Magallon J., Nguyen M., Feric N. T., Koschinsky M. L., Harkewicz R., Witztum J. L., Tsimikas S., Golenbock D., Moore K. J., Tabas I., Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metabolism 2010 12 5 467 482 2-s2.0-77958532945 10.1016/j.cmet.2010.09.010
70. Cho T., Jung Y., Koschinsky M. L., Apolipoprotein(a), through its strong lysine-binding site in KIV 10, mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway. Journal of Biological Chemistry 2008 283 45 30503 30512 2-s2.0-57649155195 10.1074/jbc.M802648200
71. Etienne-Manneville S., Hall A., Rho GTPases in cell biology. Nature 2002 420 6916 629 635 2-s2.0-0037069690 10.1038/nature01148 (Pubitemid 36764489)
72. Pellegrino M., Furmaniak-Kazmierczak E., LeBlanc J. C., Cho T., Cao K., Marcovina S. M., Boffa M. B., Côté G. P., Koschinsky M. L., The apolipoprotein(a) component of Lipoprotein(a) stimulates actin stress fiber formation and loss of cell-cell contact in cultured endothelial cells. Journal of Biological Chemistry 2004 279 8 6526 6533 2-s2.0-1342325431 10.1074/jbc.M309705200 (Pubitemid 38248787)
73. Scherberich A., Campos-Toimil M., Rondé P., Takeda K., Beretz A., Migration of human vascular smooth muscle cells involves serum-dependent repeated cytosolic calcium transients. Journal of Cell Science 2000 113 4 653 662 2-s2.0-0034093575 (Pubitemid 30133043)
74. Pokrovsky S. N., Ezhov M. V., Il'Ina L. N., Afanasieva O. I., Sinitsyn V. Y., Shiriaev A. A., Akchurin R. S., Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery 2003 126 4 1071 1075 2-s2.0-0142244772 10.1016/S0022-5223(03)00365-9 (Pubitemid 37305692)